Curis Inc (CRIS)
15.60
+0.33
(+2.16%)
USD |
NASDAQ |
Apr 17, 16:00
15.60
0.00 (0.00%)
After-Hours: 17:28
Curis Shareholders Equity (Quarterly): 19.67M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 19.67M |
September 30, 2023 | 29.59M |
June 30, 2023 | 26.22M |
March 31, 2023 | 36.59M |
December 31, 2022 | 46.55M |
September 30, 2022 | 55.74M |
June 30, 2022 | 62.04M |
March 31, 2022 | 75.97M |
December 31, 2021 | 90.71M |
September 30, 2021 | 102.91M |
June 30, 2021 | 112.47M |
March 31, 2021 | 121.92M |
December 31, 2020 | 130.67M |
September 30, 2020 | -28.61M |
June 30, 2020 | -30.38M |
March 31, 2020 | -40.27M |
December 31, 2019 | -33.91M |
September 30, 2019 | -26.02M |
June 30, 2019 | -20.27M |
March 31, 2019 | -13.73M |
December 31, 2018 | -4.496M |
September 30, 2018 | 0.782M |
June 30, 2018 | 7.11M |
March 31, 2018 | 14.47M |
December 31, 2017 | 23.99M |
Date | Value |
---|---|
September 30, 2017 | 30.45M |
June 30, 2017 | 9.228M |
March 31, 2017 | 21.48M |
December 31, 2016 | 29.27M |
September 30, 2016 | 37.87M |
June 30, 2016 | 46.19M |
March 31, 2016 | 55.94M |
December 31, 2015 | 64.51M |
September 30, 2015 | 75.99M |
June 30, 2015 | 80.58M |
March 31, 2015 | 87.62M |
December 31, 2014 | 29.78M |
September 30, 2014 | 34.65M |
June 30, 2014 | 39.41M |
March 31, 2014 | 40.54M |
December 31, 2013 | 45.17M |
September 30, 2013 | 41.57M |
June 30, 2013 | 32.76M |
March 31, 2013 | 30.25M |
December 31, 2012 | 34.27M |
September 30, 2012 | 45.72M |
June 30, 2012 | 47.05M |
March 31, 2012 | 47.60M |
December 31, 2011 | 39.88M |
September 30, 2011 | 32.41M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-40.27M
Minimum
Mar 2020
130.67M
Maximum
Dec 2020
38.51M
Average
36.59M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Kura Oncology Inc | 397.27M |
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 75.18M |
Protalix BioTherapeutics Inc | 33.57M |
Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 77.28M |
Total Liabilities (Quarterly) | 57.61M |
Current Ratio | 4.506 |